By comparing the mutation among the two genes and prognostic indicators (Table 3), the MM group (i.e., mutant in MYD88 and TP53) was presented with the worst prognosis in terms of ECOG score (P<0.001) and cancer stage (P=0.04). The gene discussed is TP53; the disease is Miyoshi myopathy.